In severe COVID-19, alveolar macrophages promote fibroblast proliferation and fibrosis via the TNFSF12-TNFRSF12A signaling pathway, and silencing TNFRSF12A effectively reverses these profibrotic effects [126]. This evidence concerns the gene TNFRSF12A and COVID-19.